INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 142 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $962 | -17.2% | 30,415 | +6.7% | 0.00% | 0.0% |
Q2 2023 | $1,162 | +10.1% | 28,505 | +0.7% | 0.00% | 0.0% |
Q1 2023 | $1,055 | +11.3% | 28,309 | +4.1% | 0.00% | 0.0% |
Q4 2022 | $948 | -99.9% | 27,186 | +46.4% | 0.00% | -33.3% |
Q3 2022 | $1,039,000 | -4.4% | 18,572 | -11.6% | 0.00% | 0.0% |
Q2 2022 | $1,087,000 | -42.2% | 21,005 | -18.8% | 0.00% | -25.0% |
Q1 2022 | $1,880,000 | -40.2% | 25,875 | -2.6% | 0.00% | -42.9% |
Q4 2021 | $3,142,000 | -11.3% | 26,579 | +0.7% | 0.01% | -22.2% |
Q3 2021 | $3,541,000 | -19.3% | 26,397 | -2.6% | 0.01% | -18.2% |
Q2 2021 | $4,389,000 | +121.0% | 27,110 | +9.5% | 0.01% | +83.3% |
Q1 2021 | $1,986,000 | +48.7% | 24,758 | +0.8% | 0.01% | +50.0% |
Q4 2020 | $1,336,000 | +178.3% | 24,559 | +1.6% | 0.00% | +100.0% |
Q3 2020 | $480,000 | -4.4% | 24,169 | +1.0% | 0.00% | 0.0% |
Q2 2020 | $502,000 | +40.2% | 23,924 | -18.5% | 0.00% | 0.0% |
Q1 2020 | $358,000 | +11.2% | 29,338 | +33.3% | 0.00% | +100.0% |
Q4 2019 | $322,000 | +3.5% | 22,002 | -5.7% | 0.00% | 0.0% |
Q3 2019 | $311,000 | -15.7% | 23,325 | +3.3% | 0.00% | -50.0% |
Q2 2019 | $369,000 | +53.1% | 22,589 | +59.7% | 0.00% | +100.0% |
Q1 2019 | $241,000 | +62.8% | 14,149 | +30.2% | 0.00% | 0.0% |
Q4 2018 | $148,000 | -42.4% | 10,864 | +20.7% | 0.00% | 0.0% |
Q3 2018 | $257,000 | -0.4% | 9,001 | -4.4% | 0.00% | 0.0% |
Q2 2018 | $258,000 | +26.5% | 9,415 | -2.8% | 0.00% | 0.0% |
Q1 2018 | $204,000 | – | 9,683 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |